These defects were responsible for reduced thrombus formation under flow conditions ex vivo and protection against arterial thrombosis in platelet-specific GluN1 deficient (Grin1fl/fl-Pf4-Cre+) mice. This evidence concerns the gene PF4 and Venous thrombosis.